Frequency and Risk Factors of Penicillin and Amoxicillin Allergy in Suspected Patients with Drug Allergy.

BACKGROUND Unconfirmed beta-lactam allergy is a significant public health problem because of the limitations it imposes in drug selection. In this study, we aimed to evaluate patients referred for beta-lactam allergy to determine the frequency of confirmed beta-lactam allergy and identify some risk factors. METHODS In a prospective cohort study, all referred patients to Immunology, Asthma and Allergy Research Institute in Tehran University of Medical Sciences (between 2007 - 2009) who suspected to have beta-lactam allergy were entered into this study based on having the inclusion criteria. Follow-up was performed 6 - 8 years after the final diagnosis. Diagnosis of beta-lactam allergy relies on thorough history and specific IgE measurements (ImmunoCAP), skin prick testing (SPT), intradermal testing (IDT), patch testing, and oral drug challenge test. RESULTS Fifty-one patients with mean age of 24.5 (±18.5) years were enrolled in this study. Based on workups, beta-lactam allergy was confirmed in 16 (31.4%) patients, suspicious in 22 (43.1%) patients and ruled out in 13 (25.5%) patients.  During the follow-up, 3 patients with suspicious drug allergy consumed the culprit drug with no reaction so allergy was finally ruled out in 16 (31.4%) patients. Age, sex, atopy and family history of drug allergies were not significantly different between the patients with confirmed or ruled-out diagnosis of penicillin and amoxicillin allergy. CONCLUSION At least up to one-third of patients with a history of beta-lactam allergy are proven to be safe using the drug. Also, a clear protocol consists of serum sIgE assay and SPT can be helpful to the physicians in the health care system.

[1]  H. Gardarsdottir,et al.  The High Impact of Penicillin Allergy Registration in Hospitalized Patients. , 2016, The journal of allergy and clinical immunology. In practice.

[2]  G. Toit,et al.  Lack of uniformity in the investigation and management of suspected β‐lactam allergy in children , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[3]  A. Cheng,et al.  Antimicrobial allergy 'labels' drive inappropriate antimicrobial prescribing: lessons for stewardship. , 2016, The Journal of antimicrobial chemotherapy.

[4]  J. Trubiano,et al.  Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study) , 2016, The Medical journal of Australia.

[5]  A. Robicsek,et al.  Documenting Penicillin Allergy: The Impact of Inconsistency , 2016, PloS one.

[6]  E. Phillips,et al.  Penicillin allergy label persists despite negative testing. , 2015, The journal of allergy and clinical immunology. In practice.

[7]  A. Gonzalez-Estrada,et al.  Penicillin allergy: A practical guide for clinicians , 2015, Cleveland Clinic Journal of Medicine.

[8]  S. Albin,et al.  Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population , 2014, Allergy and asthma proceedings.

[9]  E. Macy.  Penicillin and Beta-Lactam Allergy: Epidemiology and Diagnosis , 2014, Current Allergy and Asthma Reports.

[10]  Z. Chavoshzadeh,et al.  Allergic Drug Reactions: A Cross Sectional Study , 2014 .

[11]  R. Solensky.  Penicillin allergy as a public health measure. , 2014, The Journal of allergy and clinical immunology.

[12]  P. Demoly,et al.  Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper , 2013, Allergy.

[13]  P. Demoly,et al.  Drug provocation tests: up-date and novel approaches , 2013, Allergy, Asthma & Clinical Immunology.

[14]  C. Delacourt,et al.  Allergy to betalactam antibiotics in children: results of a 20‐year study based on clinical history, skin and challenge tests , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[15]  Z. Pourpak,et al.  Adverse drug reactions in an Iranian department of adult infectious diseases. , 2009, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[16]  M. Moin,et al.  Adverse drug reactions in patients in an Iranian department of internal medicine , 2009, Pharmacoepidemiology and drug safety.

[17]  A. Romano,et al.  Patch Testing in Non-Immediate Drug Eruptions , 2008, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[18]  P. Demoly,et al.  Epidemiology of hypersensitivity drug reactions , 2005 .

[19]  P. Demoly,et al.  Diagnosis of immediate allergic reactions to beta‐lactam antibiotics , 2003, Allergy.

[20]  P. Demoly,et al.  Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations , 2003, Allergy.

[21]  R. Wiklund.  Is This Patient Allergic to Penicillin? An Evidence-Based Analysis of the Likelihood of Penicillin Allergy , 2002 .

[22]  P. Demoly,et al.  General considerations for skin test procedures in the diagnosis of drug hypersensitivity , 2002, Allergy.

[23]  P. Demoly,et al.  Drug hypersensitivity: questionnaire , 1999 .

[24]  E. Macy.  Penicillin allergy: optimizing diagnostic protocols, public health implications, and future research needs. , 2015, Current opinion in allergy and clinical immunology.

[25]  A. Bircher,et al.  Drug hypersensitivity reactions: Inconsistency in the use of the classification of immediate and nonimmediate reactions. , 2012, The Journal of allergy and clinical immunology.

[26]  Z. Pourpak,et al.  Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects. , 2008, Recent patents on inflammation & allergy drug discovery.